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Abstract 
 
Background: Many successful therapies developed for human medicine involve animal 
experimentation. With competition for public research funding and career advancement 
opportunities, animal studies focused on the translational potential may not sufficiently document 
unexpected outcomes. Such studies often have hastily developed methods with ad hoc 
modifications including the use of additional animals, leading to considerable amounts of idle, 
unprocessed data that could be used to advance veterinary science, or to refine the base animal 
model. Sheep, for example, are poorly understood models of intensive care and therefore, any 
experimental data arising from them should be interpreted with care. The hypothesis was that there 
is little information describing the development of methods of physiological data processing in 
multifaceted sheep models of intensive care and the author aimed to develop a suitable data 
processing method and to analyse the data, once processed. 
Methods: Data from 19 adult mechanically ventilated ewes undergoing intensive care in a previous 
study evaluating a form of extracorporeal life support (treatment) for acute lung injury were used to 
develop a comprehensive method for processing manual and electronically gathered clinical 
observations. Eight sheep were injured by acute smoke inhalation prior to treatment 
(injured/treated), while another eight were not injured but treated (uninjured/treated). Two sheep 
were injured but not treated (injured/untreated), while one received room air instead of smoke as the 
injury, and was not treated (placebo/untreated). The data were then analysed for 11 physiological 
categories and compared between the two treated groups. 
Results: The analysis revealed that compared with the baseline, treatment contributed to and 
exacerbated the deterioration of pulmonary pathology by reducing lung compliance and PaO2/FiO2 
ratio. The oxygen extraction index changes mirrored those of the PaO2/FiO2 ratio. Decreasing 
coronary perfusion pressure predicted the severity of cardiopulmonary injury.  
Conclusions: These novel observations could help in understanding similar pathology such as that 
which occurs in smoke inhalation animal victims of house and bush fires. A similar data processing 
method could be used when evaluating the effectiveness of other clinical interventions such as 
potentially reversible aspiration pneumonia secondary to tick paralysis in veterinary patients. 
Keywords: Sheep, critical care, smoke-induced acute smoke inhalation injury, extra-corporeal life 
support, lung compliance, PaO2/FiO2 ratio  
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Background  
During multifaceted experiments involving intensive care in large animal models in translational 
research, information regarding animal monitoring is often collected with varying accuracy, scope, 
and end-user applications. Data collection can be manual, electronic, or both [1-3]. Manually input 
data can include subjectively scored end-points such as the plane of anaesthesia, and objective data 
such as heart rate or breaths per minute. Depending on the goals of the study, some information 
may be used to validate or test novel therapies, or to understand and refine existing treatments. In 
some cases, experimental information may be gathered for scientific curiosity or for “classified” 
use, and outcomes may never be publicly available, especially if the results are negative. 
The source of data for this study was from a sheep model [2-4] being treated for smoke-induced 
acute lung injury using veno-venous extracorporeal membrane oxygenation [2], a form of 
extracorporeal life support (ECLS) developed to complement the treatment of acute lung injury in 
humans [5-7]. During this type of ECLS, venous blood is carried from the patient to a gas exchange 
device where it becomes enriched with oxygen, has carbon dioxide removed, and is returned to the 
patient’s circulation in the right heart. This method can be used for treatment, as respiratory support 
during lung transplantation, and in critically ill patients with potentially reversible respiratory 
failure [7]. The multiple advanced cardiovascular [3], respiratory, patient point-of-care procedures, 
and instrumentation associated with ECLS, even in animal experimentation, is highly data- and 
equipment-intensive. This platform is useful for developing research and methodological skills for 
in vivo animal instrumentation and the processing of large, real-time clinical data sets from 
multifaceted animal studies that can be applied to similar intensive care scenarios. An opportunity 
to develop these skills arose within the source study, which was an ongoing publicly funded animal 
experimentation study (Queensland University of Technology Animal Ethics Approval No. 
110000053). While the objectives of the primary study had a separate focus, there were 
considerable amounts of redundant raw data with potential use in veterinary science and other 
disciplines, once processed. The author hypothesised that there was little information describing the 
development of methods of physiological data processing in multifaceted large animal models of 
intensive care. 
The overall goal was to provide useful information relevant to the sheep model, itself, and to those 
interested in large animal experimentation and veterinary medicine, generally. The specific 
objectives were: 1) use the raw data from the sheep model study to create a data management 
system for tabulating large data sets from human studies using animal models and, 2) analyse that 
data to provide biological information that is not currently available for sheep receiving ECLS 
following smoke-induced acute lung injury. 
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Methods 
The study was carried out at the purpose-built Medical Engineering Facility of Queensland 
University of Technology (QUT-MERF) at the Prince Charles Hospital Campus of The University 
of Queensland [1]. In the original study, sheep inhaled standardised cotton smoke generated by a 
device that combusts material in an oxygen-deficient environment as previously described [8]. 
Briefly, 8 g of cotton towelling was combusted in a chamber with transparent walls and 400 ml tidal 
volume. One tidal volume breath (approximately 10–12 ml/kg) of the smoke was delivered to the 
sheep via plastic tubing connected to a 1-m-long tracheostomy tube. A fixed number (12) of breaths 
were given with each load of cotton over a period of approximately one minute. Serial arterial blood 
gas samples were taken to assess the effect of smoke inhalation, starting at a predetermined time 
point after the smoke breath cycles. 
 
Physiological data management system 
Raw data were obtained from a previous translational study of critical care monitoring of sheep 
undergoing treatment for smoke-induced acute lung injury involving several separate projects. Data 
were collected prior to 23 August 2013 and were obtained from two of the scientists who developed 
the base model [4] as part of a Research Higher Degree project of the author [9, 10]. All data files 
were in Microsoft® Excel 97–2003 (Microsoft Corporation, Redmond, WA, USA) format and were 
grouped per sheep and date of the experiment. Data consisted of separate files of real-time 
physiological data recorded on the hard drives of the monitoring devices (electronically acquired 
data), and parameters manually recorded by those monitoring the sheep under anaesthesia 
(manually acquired data), which included data from the electronic monitoring equipment, as back-
up if the electronic monitor malfunctioned. 
The source study involved 64 sheep, comprising eight experimental groups of eight sheep based on 
the study’s multiple objectives, subsequent modifications, and later addition of experimental 
controls. The experimental groups were classified based on: the duration of treatment (2 and 24 
hours; E2H and E24H); treatment after smoke inhalation (injury) for 2 and 24 hours (SE2H and 
SE24H); and treatment after smoke inhalation and transfusion with fresh or stored (aged) blood 
(SEF24H or SEA24H), respectively. Two additional groups included one group receiving smoke 
inhalation injury but no treatment (SC24H), and another group that inhaled room air only as the 
injury (placebo) and no treatment (C24H). Data from sheep involved in the treatment and 
transfusion studies were not included in the analysis in this study because these data were beyond 
the scope of this study. Nineteen sheep were included in the present study; data were analysed for 
16 sheep with robust data (E24H and SE24H), and included, but not analysed, for three from groups 
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SC24H and C24H (early observational data). A systematic approach was developed for processing 
the data.  
 
Manually acquired physiological data workflow 
A clone of the master manual data entry spreadsheet was created by removing the formatting and 
formulas. Several members of the sheep ECMO research team inspected data repeatedly for errors 
to ensure that all columns, rows, time points, and data points had been copied correctly, including 
number formats (Figure 1). Redundant columns were removed and data were aligned to 
experimental time points (Figure 2). While maintaining the same experimental time point header, 
data from the table in Figure 2 were split and grouped into the following categories: ventilator 
settings, blood pressure and haemodynamics, fluids and urine output, arterial blood gas values, 
activated clotting time, anaesthetics, anticoagulants, and ECLS circuit observations. 
 
Electronically acquired physiological data workflow 
Raw electronically acquired physiologic monitoring data were inspected for completeness. The data 
comprised 36 time points: ECLS pump time (min); time of day (h); electrocardiograph (heart rate); 
arterial blood pressure (mean, systolic, diastolic, heart rate); central venous pressure (mean); 
pulmonary artery pressure (mean, systolic, diastolic); oxygenator pressure (pre- and post-); 
capnography (end-tidal carbon dioxide (etCO2), respiratory rate); pulse oximetry (SpO2, heart rate); 
ECLS pump (flow rate, speed); ventilator (mode, frequency, oxygen, pressure control, inspiratory 
volume, expiratory volume, expiratory minute volume, pressure maximum, mean pressure, positive 
end-expiratory pressure, plateau pressure, inspiratory resistance, expiratory pressure, pulmonary 
compliance, inspiratory flow); mixed venous oxygen saturation (SvO2); and continuous cardiac 
output (CCO) (Figure 3). The yellow line in Figure 3 indicates the baseline time point and the grey 
line represents the smoke inhalation time point. It is important to note that there may or may not 
have been any data at any given point in time. 
The electronically acquired physiological monitoring data were inspected for errors and cleaned to 
provide data for downstream analysis (Figure 4). 
 
Pre-data analysis checks 
Data were then subjected to further integrity checks. An important step was to make a plot of data 
versus time together with descriptive statistics for all data points in the grouped data. At the time of 
data processing, the “Descriptive Statistics” tool of Microsoft® Excel 2010 (Microsoft Corporation) 
did not complete analysis with missing values. Therefore, the data to be analysed were selected and 
then the “GoTo” tool (F5) was used, and “Special”, “Blanks”, and thereafter, “OK” were selected to 
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identify blanks. The blanks were deleted by positioning the cursor in the blank cell and using the 
space bar to clear the cell (the “Delete” or “Backspace” keys did not remove the blanks). 
After artefact removal and integrity checks, data for individual sheep were placed into six 
categories: activated clotting time; anaesthetics + inotropes and anticoagulants; arterial blood gas 
values; blood pressure + ventilation and haemodynamic data; calculated respiratory + 
haemodynamic variables; and fluids and urine production. Using specially written macros, data 
were extracted from each experiment and grouped by parameter corresponding to experimental time 
points. All sheep treatment data were filed by parameter. 
Data from the 19 sheep from groups E24H, SE24H, C24H and SC24H (Figure 5) were processed 
further. Data integrity checks were again performed and repeated by several sheep ECMO research 
team members, and data were compiled as shown in Figure 6 (note the obliterated cells after 
removal of data artefacts). The treatment timeline (a) comprised 22 time points for all experiments 
where sheep received smoke inhalation acute lung injury (SE24H) (b). A trend plot (c) and 
descriptive statistics panel (d) were useful in data quality control processes for suitability for 
downstream data analysis and end-user applications. 
 
Statistical methods  
To meet the second objective, data from the groups, uninjured/treated and injured/treated groups 
were analysed. The means, medians and standard deviations of the weights of the sheep, where 
applicable, were tabulated. The physiological parameters of the groups were charted and compared 
against each other using one-way analysis of variance (ANOVA), where appropriate. Parameters 
between groups were compared using a paired two-tailed t-test. All p-values were two-sided and p < 
0.05 was considered statistically significant. All statistical calculations were performed using 
GraphPad PRISM 6 software (GraphPad Software, La Jolla, CA, USA). 
 
Results 
The biodata of the sheep that were used in the current analysis are presented in Table 1. The 
weights of the uninjured/treated sheep, unlike the injured/treated group, did not pass the 
D’Agostino–Pearson omnibus normality test; however, there was no significant difference in the 
weights of the sheep between groups. 
 
Ventilation 
All animals were intubated and received mechanical ventilation as previously described [1]. Briefly, 
the initial ventilator tidal volume was set to approximately 10 mL/kg with a respiratory rate of 15 
breaths/min, positive end expiratory pressure (PEEP) of 5 cm H2O, and an initial FiO2 (fraction of 
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inspired oxygen) of 1.0. These settings were then titrated based on arterial blood gas results. A low 
tidal volume, high PEEP strategy was used to minimise ventilator-induced lung injury. 
Pulmonary compliance decreased in all of the sheep during the course of the experiments, with the 
injured/treated (SE24H) animals having the most severe and drastic decrease followed by the 
uninjured/treated (E24H), injured/untreated (SC24) and placebo/untreated (C24) sheep in that order 
(Figure 7). There was a significant difference (p = 0.0013) in pulmonary compliance between 
uninjured/treated and injured/treated groups. The injured/treated sheep had consistently lower SpO2 
compared with the other groups, but there was no significant difference in SpO2 readings between 
the groups. There was an initial increase in etCO2 followed by a rapid decrease that lessened 15 
minutes after the start of treatment. The etCO2 of the injured sheep continued to trend downward 
and plateaued in the uninjured groups. There was a significant difference (p = 0.0147) in etCO2 
between the uninjured/treated and injured/treated groups. 
 
Blood gases (arterial samples) 
Blood pH varied between the groups. The placebo/untreated sheep had the highest pH while the 
injured/treated group had the lowest. There was a significant difference in pH between the 
uninjured/treated and injured/treated groups (p = 0.0343). 
The pCO2 in all but the uninjured/treated sheep increased initially before plummeting sharply, 
forming a shallow trough corresponding to 1 hour after the start of treatment, followed by a slight 
increase before stabilising in all sheep.  
There was a gradual decrease in pO2 in the treated groups of sheep from baseline before decreasing 
dramatically at the start of treatment with the injured sheep having the most profound decrease 
(Figure 8). However, there was no significant difference in pO2 between the uninjured/treated and 
injured/treated groups. 
Haemoglobin [Hb] concentration decreased slightly from baseline before gradually increasing in the 
injured sheep and remained relatively constant over time in the uninjured sheep. There was a 
significant difference in [Hb] between the uninjured/treated and injured/treated (p = 0.0131) groups. 
The fraction of oxyhaemoglobin (FO2Hb) decreased sharply with the lowest reading at 5 minutes 
post-injury before returning to near baseline levels within an hour of starting treatment. The 
injured/treated sheep had a considerably deeper trough in FO2Hb level and there was a significant 
difference (p = 0.046) between troughs. There was no change in FO2Hb for the uninjured sheep.  
The fraction of carboxyhaemoglobin (FCOHb) increased sharply from baseline, peaking at 
approximately 5 minutes post-injury and decreased sharply thereafter to the start of treatment before 
gradually returning to near baseline levels at approximately 6 hours post-start of treatment in the 
injured sheep. The injured/treated sheep had a higher peak FCOHb than the injured/untreated sheep, 
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although the difference was not significant. There was no change in FCOHb for the uninjured 
sheep. 
The fraction of methaemoglobin (MetHb) increased gradually from baseline, peaking at 
approximately 5 minutes post-injury and then gradually decreased to the start of treatment. This was 
followed by a gradual return to near baseline levels at approximately 6 hours post-start of treatment 
in the injured/treated sheep. There was no change in MetHb for the uninjured sheep. There was an 
initial subtle decrease in calculated haematocrit (Hct) before a steady increase in the injured sheep 
and relatively flat slopes for the uninjured sheep.  
 
Electrolytes 
The blood sodium concentration [Na
+
] was relatively stable and there were no significant 
differences between groups. 
There was an initial decrease in the blood calcium [Ca
2+
] level, with the lowest point at 
approximately 1 hour past the start of treatment before levelling out thereafter in all groups. There 
was a significant difference in [Ca
2+
] between the uninjured/treated and the injured/treated groups 
(p = 0.0001). The placebo/untreated and injured/treated groups maintained the highest and lowest 
levels of [Ca
2+
], respectively, throughout the experiments.  
Blood chloride [Cl
-
] levels remained stable compared with baseline levels during the initial stages 
and then increased gradually thereafter. 
The blood potassium concentration [K
+
] initially decreased compared with baseline levels, reaching 
a minimum concentration 1 hour after starting treatment and then gradually increased with a peak at 
approximately 12 hours post-treatment start in all experimental groups. Although the 
injured/untreated and injured/treated sheep had higher [K
+
] than the uninjured sheep, the differences 
were not significant.  
Overall, the anion gap decreased gradually, reaching a relatively gentle slope at approximately 6 
hours from the start of treatment and did not change significantly, thereafter. There was a gradual 
decrease in anion gap from baseline during the course of the experiments and there was no 
significant difference in anion gap between the uninjured/treated and injured/treated groups. 
  
Metabolites  
Although there was an increase in blood glucose level [Glu] for the injured/treated sheep after 6 
hours of treatment, the change was not significant. 
There was an initial decrease in lactate levels [Lac] 6 hours after the start of treatment, followed by 
a gradual increase for the injured sheep, especially for the injured/treated group. There was no 
significant difference in [Lac] between the treated groups. 
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Acid-base balance 
There was an increase in the blood base levels [Base (ecf)] that peaked 1 hour post-treatment, 
followed by a gradual decrease in the untreated group. [Base (ecf)] in the treated groups remained at 
baseline levels to 1 hour post-start of treatment, before decreasing markedly in the injured/treated 
sheep. There was a significant difference (p = 0.0257) in [Base (ecf)] between the uninjured/treated 
and injured/treated groups. 
Blood bicarbonate concentrations [HCO3
-
] increased initially in the untreated groups before 
decreasing gradually; however, levels remained higher compared with the treated sheep. 
  
Haemodynamics 
There was a gradual decrease in heart rate (HR) during the course of the experiments, with the 
placebo/untreated groups maintaining a higher HR compared with the injured/untreated, 
injured/treated, and uninjured/treated groups early in the experiments. There was no significant 
difference in HR between the uninjured/treated and injured/treated groups.  
The mean arterial blood pressure (MAP) decreased early in the experiments before subsequently 
increasing gradually, peaking at approximately the treatment start time point, before gradually 
decreasing again in all but the placebo/untreated sheep. The injured/treated groups had a 
consistently lower MAP compared with the other groups and there was a significant difference in 
MAP (p = 0.0058) between the uninjured/treated and injured/treated groups. 
The mean pulmonary artery pressure (MPAP) increased gradually, with the injured/treated group 
having a consistently higher MPAP. There was no significant difference in MPAP between the 
uninjured/treated and injured/treated groups.  
There was an initial, subtle increase in central venous pressure (CVP) that peaked at approximately 
1 hour post-injury followed by a decrease that stabilised at approximately 1 hour post-start of 
treatment. CVP levels in the injured/treated and placebo/untreated sheep were consistently higher 
and lower, respectively, during the course of the experiments. Mixed venous oxygen saturation 
(SvO2) had a lower baseline before eventually rising to a relatively stable and higher level for the 
treated sheep, and a slightly lower level for the untreated sheep. The injured/untreated sheep 
maintained a consistently lower SvO2 compared with the other groups. 
Except for the placebo/untreated group, there was a decrease in continuous cardiac output (CCO) 
from baseline to approximately 1 hour post-start of treatment. There was a significant difference (p 
= 0.0009) in CCO between the uninjured/treated and injured/treated groups with CCO in the treated 
groups increasing sharply before plateauing, especially in the uninjured/treated group. There was 
also a subsequent gradual decrease in CCO in the injured/treated group.  
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Stroke volume (SV) began to increase 1 hour from the start of treatment for all groups, except for 
the injured/untreated group where levels remained relatively constant. SV in the injured/treated 
group began to decrease after 6 hours of treatment, while SV in the uninjured/treated and 
placebo/untreated sheep increased steadily before decreasing or levelling out after 12 hours or more 
of treatment. There were no significant differences in SV between. 
Stroke volume index (SVI) began to increase 1 hour after of the start of treatment for all groups, 
except for the injured/untreated group, for which SVI remained relatively constant. SVI in the 
injured/treated group began to decrease after 6 hours of treatment while SVI in the uninjured/treated 
and placebo/untreated groups increased before subsequently decreasing or levelling out after 12 
hours or more of treatment. There were no significant differences in SVI between groups.  
While the cardiac index (CI) of the uninjured/treated and placebo/untreated groups remained 
relatively close to baseline levels, CI the injured/treated and injured/untreated groups declined 
gradually over the course of the experiments.  
After an initial increase in systemic vascular resistance index (SVRI) to approximately 1 hour after 
the start of treatment, SVRI began to decrease in all experimental groups before plateauing after 12 
hours of treatment followed by a gentle increasing trend until the end of the experiments. SVRI in 
the injured/treated group was consistently below that of the other groups during treatment while that 
of the injured/untreated group was correspondingly higher. There was no significant difference in 
SVRI between the groups. 
Pulmonary vascular resistance index (PVRI) remained close to baseline levels for all of the groups 
until 1 hour after the start of treatment when that of the injured groups progressively increased 
while that of the uninjured groups remained lower with a subtle decrease to 6 hours post-treatment. 
PVRI in the placebo/untreated sheep remained near baseline levels and the lowest throughout the 
course of the experiment. 
After a small peak corresponding to the start of treatment, right ventricular stroke work index 
(RVSWI) in the uninjured sheep gradually increased while that of the injured sheep decreased. 
There was a significant difference (p = 0.0196) in RVSWI gap between the uninjured/treated and 
injured/treated groups. RVSWI in the placebo/untreated group remained high while that of the 
injured/treated group was consistently the lowest. 
Left ventricular stroke work index (LVSWI) gradually increased in the uninjured/treated and 
placebo/untreated groups, before plateauing after 12 and 18 hours of treatment, respectively, while 
LVSWI in the injured/untreated and injured/treated groups of sheep decreased before plateauing at 
12 hours and trending upward after 18 hours of treatment. LVSWI in the placebo/untreated group 
remained consistently higher than in the other groups while that of the injured/treated group was 
consistently the lowest. 
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Following a decrease in the coronary perfusion pressure (CPP) from baseline in the smoke-injured 
sheep, there was a subsequent increase in this parameter prior to a sustained decrease at 18 hours of 
treatment, followed by another increase. There was a significant difference in CPP (p = 0.0018) 
between the uninjured/treated and injured/treated groups and CCP in the placebo/untreated sheep 
remained relatively stable after an initial, subtle increase. 
There was an initial subtle decrease in arterial oxygen content (CaO2) from baseline in all groups 
before a sustained increase in the injured/untreated group, a steady level in the placebo/untreated 
sheep, and a sharp trough in the injured/treated and uninjured/treated groups. Following the trough, 
the CaO2 of the injured/treated group gradually returned to baseline levels while that of the 
uninjured/treated group continued on a downward trend. There was a significant difference (p < 
0.0085) in CaO2 between the uninjured/treated and injured/treated groups. 
There was a slight decrease in the oxygen delivery index (DO2I) in all groups to 1 hour of treatment 
before a further marked decrease, except for the placebo/untreated sheep. There was a significant 
difference (p = 0.0013) in DO2I between the uninjured/treated and injured/treated groups. The 
injured/treated group had the lowest DO2I compared with the other groups while the 
placebo/untreated sheep maintained the highest DO2I profile. 
The oxygen extraction index (O2EI) decreased in all groups before plateauing at approximately 6 
hours after the start of treatment. There was a significant difference (p = 0.0247) in O2EI between 
the injured/treated and uninjured/treated groups. O2EI in the injured/treated and injured/untreated 
groups was consistently lower and higher, respectively, compared with those of the other groups. 
 
Fluid input and urine output 
The volume of intravenous fluids administered to sheep in the different experimental groups varied. 
The injured/treated sheep had the highest fluid requirements while the placebo/untreated sheep 
required the least. There was a significant difference (p < 0.0001) in fluid requirements between 
uninjured/treated and injured/treated sheep. 
The injured/untreated and injured/treated groups produced the least and most urine on average, 
respectively. There was no significant difference in urine output between the uninjured/treated and 
injured/treated groups. 
 
Anaesthetics 
There was a significant difference (p < 0.0001) in the amount of alfaxalone required between the 
uninjured/treated and injured/treated groups. The uninjured/treated group required more alfaxalone 
on average and the injured/untreated group required the least amount on average. Ketamine 
requirements differed between groups, with the injured/untreated group requiring the highest 
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amount on average and the injured/treated group requiring the least. There was no significant 
difference in the quantities of ketamine required between the uninjured/treated and injured/treated 
groups but significant differences in midazolam requirements occurred between the 
uninjured/treated and injured/treated groups (p = 0.0067). 
 
Anticoagulation 
There were no significant differences in heparin infusion doses between the uninjured/treated and 
injured/treated sheep. Heparin requirements for the placebo/untreated group were the lowest. 
Activated clotting time increased sharply from baseline during pre-treatment and peaked 1 hour 
after the start of treatment before decreasing sharply and plateauing. There were no significant 
differences in activated clotting time between groups. 
 
ECLS circuit observations 
There were significant differences in the ECLS pump speed, blood flow, and pressure differential 
between the uninjured/treated and injured/treated groups. Pump speed, blood flow, and pressure 
differential were significantly different (p = 0.0022), (p = 0.0095) and (p = 0.0041), respectively, 
between the two groups receiving ECLS. These parameters in the uninjured/treated group were 
consistently higher than those of the injured/treated group. 
 
Body temperature 
Body temperature in the untreated groups gradually increased from baseline levels and plateaued at 
approximately 6 hours after starting treatment, and remained higher than for the treated groups. 
There was no significant difference in body temperature between the treated groups. 
 
Inflammatory cells and cytokines 
Data were available in abstract form on inflammatory cell infiltration into the lung tissue with a 
trend toward increased lung injury in the sheep that inhaled smoke, showing damage to the 
bronchiolar lining and infiltration of inflammatory cells [11-13]. 
 
 
Discussion 
The results of this study agree with and confirm earlier preliminary observations that ECLS causes 
a decrease in pulmonary compliance over time [9]. It was expected that the injured sheep would 
have relatively lower SpO2 readings compared with the other groups because of episodes of 
hypotension with hypoxemia, which can affect pulse oximeter function [14]. The relatively low 
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etCO2 in the injured sheep suggested that the sheep may have hyperventilated, the causes of which 
were evaluated with respect to reactive oxygen species or superoxide dismutase activity by a team 
from the source study [15, 16]. 
The relatively low blood pH in the injured/treated sheep suggested that the sheep tended to 
metabolic acidosis as the same group of animals also had low etCO2. This also means that there was 
no respiratory component contributing to the observed acidosis. The low pCO2 in the 
uninjured/treated sheep could be a result of hyperventilation and the high pCO2 in the 
injured/untreated sheep suggested that CO2 clearance was curtailed by injury. 
The treatment of the sheep contributed to lung injury by causing deterioration of pO2. The low pO2 
translated to low partial arterial oxygen pressure/inspired oxygen fraction (PaO2/FiO2) ratio, which 
was much worse in the injured sheep. This finding showed that ECLS contributed to the 
deterioration of the PaO2/FiO2 ratio in the injured/treated group of sheep, a novel finding that was 
also unexpected in the primary study. 
The relatively higher levels of [Hb] in the injured sheep suggested that these animals could have 
been dehydrated secondary to excessive fluid loss from inflammation and increased vascular 
permeability [17] despite intravenous fluid replacement. However, blood total protein and albumin 
levels, better predictors of dehydration in sheep [18], were not measured. 
The inverse decrease in FO2Hb relative to FCOHb following smoke injury was expected and agreed 
with other studies [17, 19, 20]. It has recently been demonstrated that FCOHb is not correlated to 
the degree of lung injury [17]. The gradual decrease in MetHb was probably caused by the 
enzymatic activity of methaemoglobin reductase [21] and the higher Hct observed in the injured 
sheep could have been due to dehydration because HCT was measured by an automated method. 
The [Ca
2+
] was lower than the published normal level of 2.4 mmol/L [22]. Stress associated with 
yarding of the sheep and phosphorus imbalance in feed are the most likely suggested causes of low 
[Ca
2+
] [23]. Fasting the sheep for 24 hours prior to the experimental procedures could also have 
contributed to the relatively low [Ca
2+
].  
The increase in [Cl
-
] beyond the normal range of 105 –110 mmol/L [22] during the experiments 
suggests that the sheep may have developed respiratory alkalosis. Hyperventilation or metabolic 
acidosis resulting from sustained salivary loss of sodium bicarbonate that was more severe in the 
injured/treated group may have played a role hyperchloraemia, because Cl
-
 is known to replace 
HCO3
-
 in the latter’s loss [24, 25]. Baseline [K+] in all of the sheep was below the published normal 
range of 4–5 mmol/L [22] and this relative hypokalaemia may have been related to low [K+] in the 
diet [26-28]. The normal anion gap with decreased HCO3
-
 confirmed the presence of 
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hyperchloraemic acidosis in all but the placebo/untreated sheep. The cause of the hyperchloraemia 
was likely the prolonged administration of 0.9% NaCl. 
Although normal [Glu] in ruminants is usually lower than for other species, its relative progressive 
increase in the injured sheep may have been related to stress and severe pain associated with injury 
or the development of enterotoxaemia [29, 30]. The relative increase in [Lac] beyond the reported 
normal range of 1–2 mmol/L in the injured sheep suggested dehydration, trauma, and sepsis [31]. 
Sepsis, in particular, is a concern with sub-optimal rumen function leading to loss of its buffer effect 
and increasing numbers of anaerobic bacteria with prolonged hypomotility, such as occurs during 
long-duration anaesthesia. Therefore, the increases in both [Glu] and [Lac] are consistent with 
severe injury. 
The elevated [Base (ecf)] above +2 mmol/L for most of the first 12 hours in the placebo/untreated 
and injured/untreated sheep suggested that the sheep were metabolically alkalotic [29] before 
returning to normal levels. The relatively low [Base (ecf)] (less than −2 mmol/L) was consistent 
with HCO3
-
 loss and the tendency to metabolic acidosis [29] in the injured/treated sheep. The 
marked decrease in [HCO3
-
] in the injured sheep was consistent with metabolic acidosis and was 
more severe in the injured/treated group, suggesting that ECLS was a contributing factor. 
The resting HR of sheep is 50–80 beats/min [22]. In a study that instrumented conscious sheep, the 
baseline heart rate was registered as 106 ± 9 beats/min [32]. In the present report, all of the sheep 
had a relatively high HR, suggesting that stress and pain were contributing factors. The gradual 
decrease in HR during the course of the experiments was consistent with the effects of anaesthesia 
[22]. 
In sheep, a mean arterial pressure below 60 mmHg indicates inadequate tissue perfusion [22]. 
Although the MAP values in the injured sheep were lower than for the uninjured, MAP values were 
still within the published normal value of 70 mmHg [22]; the magnitude of injury was again a 
predictor of how low the MAP was. Another predictor for the severity of the injury was the mean 
pulmonary artery pressure, which was highest for the injured/treated sheep. The baseline values for 
MPAP were higher than the 17 ± 1 mmHg reported in another study using sheep [32]. The baseline 
CVP in all of the sheep in the present report was > 10 mmHg, which was much higher than the 5.5 
± 1.2 mmHg reported elsewhere [32] in instrumented conscious sheep and a novel finding in this 
study. The severity of injury and treatment contributed to the CVP elevations in this study. 
There was a benefit of ECLS treatment for SvO2 as it remained high for both the injured/treated and 
uninjured treated groups. The consistently low SvO2 in the injured/untreated group was expected 
because of the slightly reduced cardiac output in this group; however, this level of SvO2 was still 
higher than that reported in other studies [32]. Smoke injury was associated with a sustained 
decrease in cardiac output in all of the sheep that were exposed to smoke. As in CCO changes, the 
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SV, SVI and CI all had similar profiles for the different groups, with the injured sheep having lower 
values. The decrease in SVRI in all of the sheep later in the experiments suggested that there was 
systemic vasodilation. In contrast, the increase in PVRI in the injured sheep suggested that 
vasoconstriction was caused by exposure to smoke injury. The exposure to smoke injury worsened 
both RVSWI and LVSWI while there was an increase in both parameters in the uninjured sheep. 
Reduced RVSWI is associated with poor functioning of the right ventricle [33, 34] and LVSWI is a 
reliable parameter for left ventricular function [35]. 
The reduction in coronary perfusion pressure in the injured/treated, and to a certain extent the 
uninjured/ treated sheep, suggested that ECLS contributed to the decrease in CPP, in addition to 
smoke injury. CPP is an indicator of myocardial perfusion and has been proposed as a drug target 
during resuscitation [36]. The observations in the present study support the suggestion that CPP 
could be used to predict the severity of injury in sheep. 
The apparent increase in CaO2 in the injured sheep could have been due to the relative increase in 
[Hb] secondary to dehydration. The low DO2I in the injured/treated and uninjured/treated groups 
suggested that ECLS had a contribution, in addition to smoke, based on the relatively higher DO2I 
in the injured/untreated sheep. Interestingly, the O2EI had a comparable profile to that of the 
PaO2/FiO2 ratio, and could also be used to predict the contribution of ECLS to smoke-related injury. 
The smoke-injured sheep required considerable amounts of intravenous fluids to compensate for the 
losses from pulmonary exudation and inflammation [17, 19]. The mean urine production in all 
groups was marginally lower than the published normal of 1.2 mL/h [22] but still considered to be 
within the acceptable range for this cohort of sheep. The amount of anaesthetic drugs used was 
considered adequate for the experiments. Heparin infusion was indicated to prolong the activated 
clotting time to minimise the risk of thrombosis during intravascular procedures [37]. 
The reduction in the ECLS pump speed, flow, and the pressure differential could have resulted from 
systemic hypotension contributing to low amounts of blood to the pump. The ECLS was configured 
such that the centrifugal pump pulled blood from the inferior vena cava and returned it into the right 
atrium; therefore, if the circulating volume was low, the flow would decrease for a given pump 
speed and in this case, both rpm and flow dropped. Centrifugal ECLS pumps are known to be 
preload dependent and afterload sensitive [38], making rpm and flows directly proportional to each 
other. The reason for the systemic hypotension remains undetermined. It is possible that an 
unknown pulmonary component or product produced in the smoke-damaged lungs played a role. 
The body temperature of the sheep was generally within the physiological range. 
Certain observations about this study could affect the interpretation of red blood cell indices and 
their derivatives. For instance, animals differ from humans in that estimated changes in plasma 
volume is preferably determined by changes in packed cell volume (PCV) or haemoglobin 
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concentration and total plasma protein (TPP) [39-41]. Also, in animals, there is a wider range of 
normal PCV than TPP [42]. In domestic animal critical care, the change in both PCV and TPP is 
most useful as a crude index of change in plasma volume [43]. A centrifuge that spins minute 
amounts of blood for rapid, cost-effective determination of PCV and TPP permits instant 
adjustments in the animal’s fluid needs. However, measurements of PCV and TPP were not made in 
the primary study. As with all data that are collected with different objectives, it was considerably 
tedious to align certain time points with real-time observations made in the laboratory, especially 
for the manually input data. There was also no information about pre-anaesthetic blood tests. 
An additional limitation relates to the first objective of creating a data management system for 
tabulating large data sets from human studies using animal models. Because the method has not 
been validated, it is considered preliminary and further validation studies are required. Also, the 
numbers of sheep were low and this was especially so in the injured/untreated and 
placebo/untreated groups, preventing comparisons between the treated and untreated sheep. A 
further limitation is that cytokine levels, as predictors of lung injury, were not quantified. Using 
ELISA assays to quantify cytokine levels proved difficult and the cost was prohibitive in the present 
study. It is partly for this reason that pioneering studies for the development of proteogenomic 
assays were proposed [44] as an alternative  to ELISA to learn from circulating markers of acute 
inflammation in injured sheep used as models of intensive care, to understand critical illness. 
 
Conclusions  
The results of this study demonstrated that this preliminary method of raw data processing was 
effective and helped show that ECLS contributed to further worsening of pulmonary pathology by 
reducing lung compliance and PaO2/FiO2 ratio. The O2EI changes mirrored those of the PaO2/FiO2 
ratio, and decreasing CPP was a predictor of a greater magnitude of cardiopulmonary injury in 
sheep. These novel observations further understanding of similar pathology in other patients; for 
instance, in the resuscitation of smoke-injured animals in house or bush fires. A similar data 
processing approach could be used in evaluating the effectiveness of a given experimental or 
clinical intervention to further the understanding of the clinical condition being studied, and to aid 
in the formulation of treatments aimed at improving the survival of animal patients. In veterinary 
medicine, albeit now a considerably expensive and remote option, ECLS knowledge could 
complement the treatment of potentially reversible aspiration pneumonia, a secondary complication 
associated with both Ixodes holocyclus toxicity and laryngeal paralysis, in valuable companion 
animals. 
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Figure Legends 
Figure 1. Uncleaned manually input extra-corporeal membrane oxygenation (ECMO) treatment 
monitoring data in sheep 
Figure 2. Cleaned and time-point annotated manually input extra-corporeal membrane oxygenation 
(ECMO) treatment monitoring data in sheep 
Figure 3. Uncleaned electronically acquired physiological monitoring and treatment data during 
extra-corporeal membrane oxygenation (ECMO) in sheep 
Figure 4. Cleaned electronically acquired physiological monitoring and treatment data during extra-
corporeal membrane oxygenation (ECMO) in sheep 
Figure 5. Data integrity checks and artefact removal of physiological monitoring and treatment data 
during extra-corporeal membrane oxygenation (ECMO) in sheep 
Figure 6. Completed extra-corporeal membrane oxygenation (ECMO) treatment data sheet in sheep 
listed by parameter for further data analysis 
a: treatment timeline, b: all experiments where sheep received smoke inhalation acute lung injury 
(SE24H), c: parameter trend plot, and d: descriptive statistics panel 
Figure 7. Pulmonary compliance of smoke and non-smoke injured sheep receiving extracorporeal 
membrane oxygenation (ECMO) support alongside untreated controls 
Dotted lines represent error bar margins. Values are presented as mean ± standard deviation. 
Figure 8. Arterial oxygen tension for injured and uninjured sheep receiving extracorporeal 
membrane oxygenation (ECMO) support alongside untreated controls 
Arterial oxygen tension (pO2) values are presented as mean ± standard deviation with no error bars 
shown. 
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Figures 
Figure 1. Uncleaned manually input extra-corporeal membrane oxygenation (ECMO) treatment 
monitoring data in sheep 
 
 
Figure 2. Cleaned and time-point annotated manually input extra-corporeal membrane oxygenation 
(ECMO) treatment monitoring data in sheep 
 
  
25 
 
Figure 3. Uncleaned electronically acquired physiological monitoring and treatment data during 
extra-corporeal membrane oxygenation (ECMO) in sheep 
 
 
Figure 4. Cleaned electronically acquired physiological monitoring and treatment data during extra-
corporeal membrane oxygenation (ECMO) in sheep 
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Figure 5. Data integrity checks and artefact removal of physiological monitoring and treatment data 
during extra-corporeal membrane oxygenation (ECMO) in sheep 
 
 
Figure 6. Completed extra-corporeal membrane oxygenation (ECMO) treatment data sheet in sheep 
listed by parameter for further data analysis a: treatment timeline, b: all experiments where 
sheep received smoke inhalation acute lung injury (SE24H), c: parameter trend plot, and d: 
descriptive statistics panel 
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Figure 7. Pulmonary compliance of smoke and non-smoke injured sheep receiving extracorporeal 
membrane oxygenation (ECMO) support alongside untreated controls 
Dotted lines represent error bar margins. Values are presented as mean ± standard deviation. 
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Figure 8. Arterial oxygen tension for injured and uninjured sheep receiving extracorporeal 
membrane oxygenation (ECMO) support alongside untreated controls 
Arterial oxygen tension (pO2) values are presented as mean ± standard deviation with no error bars 
shown. 
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Tables and captions 
Table 1 Subject characteristics in treated and untreated groups (control experiments) of sheep 
Experiment 
Group 
Date Sheep No. Age (Y) Weight (kg) Length (m) BSA 
E24H 06/10/2011 E24H-01/390 2 50 110 1.29 
 20/10/2011 E24H-02 2 47.6 110 1.25 
 17/11/2011 E24H-03 2 51 110 1.31 
 01/03/2012 E24H/4616 2 50 110 1.29 
 29/03/2012 E24H-05/4627 2 47 110 1.24 
 04/04/2012 E24H-06/4146 2 40 110 1.11 
 12/04/2012 E24H-07/4032 2 52.5 110 1.34 
 03/05/2012 E24H-08/4630 2 53 110 1.34 
SE24H 02/02/2012 SE24H-01/4139 2 44 110 1.19 
 09/02/2012 SE24H-02/4542 2 53 110 1.34 
 16/02/2012 SE24H-03/4280 2 45.5 110 1.21 
 23/02/2012 SE24H-04/4624 2 50 110 1.29 
 17/05/2012 SE24H-05/4458 2 55 140 1.38 
 24/05/2012 SE24H-06/8461 2 46 140 1.22 
 24/01/2013 SE24H-07/09C8032 3 52 130 1.33 
 21/02/2013 SE24H-09A0142 2 50 140 1.29 
SC24H 18/06/2013 SC24H-01 2 51 140 1.31 
 27/06/2013 SC24H-02 2 57 140 1.41 
C24H 08/08/2013 C24H-01 2 53 140 1.34 
Key: BSA=Body surface area; E24H=Uninjured sheep treated with extracorporeal life support 
(ECLS) for 24 hours (uninjured/treated); SE24H= Smoke-induced acute lung injured sheep treated 
with ECLS for 24 hours (injured/treated); SC24H= Smoke-induced acute lung injured sheep 
monitored for 24 hours without ECLS (injured/untreated); C24H=Sheep subjected to room air 
injury as a control for smoke and monitored for 24 hours without ECLS (placebo/untreated). 
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research project with a separate focus. However, it is not exactly clear which study this is or who is 
involved in this study. Could you be more specific about the researchers involved in this study and 
what published studies have already been published from it? 
 
31 
 
- In your Acknowledgements section you state that "Gratitude is extended to Dunster KR, Diab S 
and Platts D for considerable assistance in the animal laboratory and sharing data". Could you be a 
bit more specific about any permissions you required to use this data and specifically state that these 
researchers gave you explicit permission to use data arising from their study (if this was the case). 
------------------------------------------- 
We would be grateful if you could address the comments in a revised manuscript and provide a 
cover letter giving a point-by-point response to the concerns. 
Please also ensure that your revised manuscript conforms to the journal style 
(http://www.biomedcentral.com/bmcresnotes/ifora/). It is important that your files are correctly 
formatted. 
We look forward to receiving your revised manuscript by 4 August 2015. If you imagine that it will 
take longer to prepare please give us some estimate of when we can expect it. 
You should upload your cover letter and revised manuscript through 
http://www.biomedcentral.com/manuscript/login/man.asp?txt_nav=man&txt_man_id=1245248645
165367. You will find more detailed instructions at the base of this email. 
Please don't hesitate to contact me if you have any problems or questions regarding your 
manuscript. 
With best wishes, 
 
Dr Christopher Foote 
Executive Editor 
Tel: +44 (0) 20 3192 2013 
e-mail: researchnotes@biomedcentral.com 
Web: http://www.biomedcentral.com/ 
------------------------------------------------------- 
From: Saul Chemonges 
Sent: 24 July 2015 23:30 
To: BioMed Central Editorial 
Subject: Re: 1245248645165367 - Learning from critical care management of sheep receiving 
extra-corporeal membrane oxygenation for smoke-induced acute lung injury as a tool for processing 
large clinical datasets 
 
Dear Dr Christopher Foote, 
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I  addressed the comments in a revised manuscript and provided a cover letter giving a point-by-
point response to the editorial concerns and resubmitted the manuscript on 7th July 2015. 
When I logged in the tracking system today, there's a message that reads "Please go to 
https://www.editorialmanager.com/resn to track and manage those manuscripts."  I was wondering 
if I should have made the resubmission through the new editorial manager instead. 
 
Kind regards, 
Saul Chemonges 
--------------------------------------------- 
From: Foote, Christopher <Christopher.Foote@biomedcentral.com> 
Sent: 07 November 2015 02:32 
To: Saul Chemonges 
Subject: Your submission to BMC Research Notes  
  
MS: 1245248645165367 
Research article 
Learning from critical care management of sheep receiving extra-corporeal membrane oxygenation 
for smoke-induced acute lung injury as a tool for processing large clinical datasets 
Saul Chemonges 
BMC Research Notes 
  
Dear Dr Chemonges, 
  
I am writing to you regarding your submission (above) to BMC Research Notes. Thank you for 
responding to our previous request for clarification over the source of the data used in your paper. 
My apologies for how long it has taken us to respond. 
  
We do still have some further clarifications we hope you can provide. Would you be able to answer 
the following questions: 
  
-          Can you confirm that this manuscript reports data collected during a year that you spent 
working with John Fraser in his lab? 
  
-          Can you confirm that it is correct that you are the only person who qualifies for 
authorship on this paper? BMC Research Notes follows the ICMJE guidelines for 
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authorship, which I paste below. Based on these guidelines can you confirm that you are the 
only person who meets these criteria for authorship on this paper? 
  
An 'author' is generally considered to be someone who has made substantive intellectual 
contributions to a published study. According to the International Committee of Medical Journal 
Editors (ICMJE) guidelines, to qualify as an author one should have: 
1. made substantial contributions to conception and design, or acquisition of data, or analysis 
and interpretation of data; 
2. been involved in drafting the manuscript or revising it critically for important intellectual 
content; 
3. given final approval of the version to be published. Each author should have participated 
sufficiently in the work to take public responsibility for appropriate portions of the content; 
and 
4. agreed to be accountable for all aspects of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved. 
Acquisition of funding, collection of data, or general supervision of the research group, alone, does 
not usually justify authorship. 
-          Can you confirm that you have all the necessary permissions to use and publish the data 
contained in your manuscript? 
  
 I hope you do not object to providing this further clarification on these issues. I am sure you can 
appreciate it is important for us to be sure of these issues before we publish a paper. As part of this, 
we also plan to contact John Fraser to ask him to confirm that he is happy for you to utilise and 
publish this data collected in his lab and that he agrees you should be the only author on the paper. 
  
I look forward to hearing from you. 
  
Best wishes, 
Dr Christopher Foote 
  
Executive Editor 
BMC Research Notes 
Floor 6, 236 Gray's Inn Road 
London WC1X 8HB 
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Tel: +44 (0) 20 3192 2000 
e-mail: christopher.foote@biomedcentral.com 
Web: www.biomedcentral.com/authors/bmcseries#journallist 
  
--------------------------------------- 
From: Foote, Christopher <Christopher.Foote@biomedcentral.com> 
Sent: 12 November 2015 20:45 
To: Saul Chemonges 
Subject: RE: Your submission to BMC Research Notes  
 Dear Dr Chemonges, 
  
I am just writing to follow up on my email from last week (below) to confirm that you received it 
and will be able to provide us with the requested clarifications regarding your study. 
  
I look forward to hearing from you. 
  
Best wishes, 
Dr Christopher Foote 
  
Executive Editor 
BMC Research Notes 
Floor 6, 236 Gray's Inn Road 
London WC1X 8HB 
Tel: +44 (0) 20 3192 2000 
e-mail: christopher.foote@biomedcentral.com 
Web: www.biomedcentral.com/authors/bmcseries#journallist 
  
 ------------------------------- 
From: Saul Chemonges <s.chemonges@uq.edu.au> 
To: John Fraser <j.fraser@uq.edu.au>  
Cc: "Christopher.Foote@biomedcentral.com" <Christopher.Foote@biomedcentral.com>; Saul 
Chemonges <s_chemonges@yahoo.com>; UQ Graduate School Dean 
<dean@gradschool.uq.edu.au> 
Sent: Saturday, 30 April 2016, 14:46 
Subject: Fw: Your submission to BMC Research Notes 
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Dear Prof John Fraser, 
 
I submitted the attached manuscript to BMC Research Notes a while back from work in my thesis 
that was conducted at CCRG Lab at TPCH. The Executive Editor (Dr Christopher Foot) has 
requested for further clarifications regarding the manuscript as detailed below. 
 
To reply to the clarifications, I intend to maintain affirmative answers to the questions raised by the 
Editor. I believe I have made the appropriate acknowledgements in the attached copy of the 
manuscript. Please kindly let me know if you have any concerns before I reply to Dr Foote. 
 
Kind regards, 
 
Saul Chemonges 
 
------------------------------------------ 
From: Saul Chemonges 
Sent: 07 May 2016 18:05 
To: Foote, Christopher 
Subject: Re: Your submission to BMC Research Notes  
  
Dear Dr Foote, 
My apologies for the delay in getting back to you regarding my article. 
I only recently returned from an unscheduled extended leave of absence. 
As you may have noticed, I have written to Prof Fraser regarding the clarifications that I copied to 
you via my other email address. Hopefully we will hear from him soon.  
Many thanks, 
Saul Chemonges 
